These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38051087)

  • 1. [Treatment with botulinum toxin of masseter hypertrophy, myalgia of the tendons and attrition induced by bruxism].
    Brand Kanters ART; Steenen SA; Gilden J; Khan M
    Ned Tijdschr Tandheelkd; 2023 Dec; 130(12):525-529. PubMed ID: 38051087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Electromyographic Changes in a Patient with Masseter Hypertrophy and Muscle Pain after Botulinum Injections: A Case Report and 5 Months Follow-up.
    Bianco E; Tagliabue R; Mirabelli L; Maddalone M
    J Contemp Dent Pract; 2022 Feb; 23(2):226-231. PubMed ID: 35748454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Masseter Muscle and Its Role in Facial Contouring, Aging, and Quality of Life: A Literature Review.
    Almukhtar RM; Fabi SG
    Plast Reconstr Surg; 2019 Jan; 143(1):39e-48e. PubMed ID: 30303926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there enough evidence to use botulinum toxin injections for bruxism management? A systematic literature review.
    De la Torre Canales G; Câmara-Souza MB; do Amaral CF; Garcia RC; Manfredini D
    Clin Oral Investig; 2017 Apr; 21(3):727-734. PubMed ID: 28255752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects.
    Quezada-Gaon N; Wortsman X; Peñaloza O; Carrasco JE
    J Cosmet Dermatol; 2016 Sep; 15(3):238-44. PubMed ID: 26799545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical investigation of botulinum toxin (prabotulinumtoxin A) for bruxism related to masseter muscle hypertrophy: A prospective study.
    Jung BK; Park H; Cheon YW; Yun IS; Choi JW; Kim HJ; Lee MY; Kang BS; Kang TJ
    J Craniomaxillofac Surg; 2023 May; 51(5):332-337. PubMed ID: 37353404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bruxism, temporo-mandibular dysfunction and botulinum toxin].
    Chikhani L; Dichamp J
    Ann Readapt Med Phys; 2003 Jul; 46(6):333-7. PubMed ID: 12928140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of botulinum toxin on jaw motor events during sleep in sleep bruxism patients: a polysomnographic evaluation.
    Shim YJ; Lee MK; Kato T; Park HU; Heo K; Kim ST
    J Clin Sleep Med; 2014 Mar; 10(3):291-8. PubMed ID: 24634627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of bruxism with botulinum toxin: think twice!].
    Lobbezoo F; Verhoeff MC; Helmers R; de Lange J; Koutris M
    Ned Tijdschr Tandheelkd; 2024 Jul; 131(7-08):331-334. PubMed ID: 38973663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin injection for bruxism associated with brain injury: case report.
    Kesikburun S; Alaca R; Aras B; Tuğcu I; Tan AK
    J Rehabil Res Dev; 2014; 51(4):661-4. PubMed ID: 25144179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
    Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M
    J Headache Pain; 2016; 17():29. PubMed ID: 27011213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Asymmetric hypertrophy of the masticatory muscles].
    Arzul L; Corre P; Khonsari RH; Mercier JM; Piot B
    Ann Chir Plast Esthet; 2012 Jun; 57(3):286-91. PubMed ID: 22455902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical Considerations When Treating Compensatory Hypertrophy of the Upper Part of the Masseter after Long-Term Botulinum Neurotoxin Type A Injections.
    Lee KL; Cho HJ; Bae H; Park HJ; Park MS; Kim HJ
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32235784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of severe bruxism with botulinum toxin type A].
    Alonso-Navarro H; Jiménez-Jiménez FJ; Plaza-Nieto JF; Pilo-De la Fuente B; Navacerrada F; Arroyo-Solera M; Calleja M
    Rev Neurol; 2011 Jul; 53(2):73-6. PubMed ID: 21720976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin treatment of temporomandibular joint pain in patients with bruxism: A prospective and randomized clinical study.
    Kaya DI; Ataoglu H
    Niger J Clin Pract; 2021 Mar; 24(3):412-417. PubMed ID: 33723117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of botulinum neurotoxin Type A in the management of primary bruxism in adults: An updated systematic review.
    Sendra LA; Azeredo Alves Antunes L; Barboza EP
    J Prosthet Dent; 2024 Jul; 132(1):93-99. PubMed ID: 35779974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onabotulinum toxin-A injections for sleep bruxism: A double-blind, placebo-controlled study.
    Ondo WG; Simmons JH; Shahid MH; Hashem V; Hunter C; Jankovic J
    Neurology; 2018 Feb; 90(7):e559-e564. PubMed ID: 29343468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bruxism after brain injury: successful treatment with botulinum toxin-A.
    Ivanhoe CB; Lai JM; Francisco GE
    Arch Phys Med Rehabil; 1997 Nov; 78(11):1272-3. PubMed ID: 9365360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases.
    Baş B; Ozan B; Muğlali M; Celebi N
    Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e649-52. PubMed ID: 20173718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Evaluation of the Relationship between Changes in Masseter Muscle Thickness and Tooth Clenching Habits of Bruxism Patients Treated with Botulinum Toxin A.
    Erdil D; Bagis N; Eren H; Camgoz M; Orhan K
    J Med Ultrasound; 2023; 31(1):22-28. PubMed ID: 37180633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.